Lowest Price Guaranteed From USD 5,499
Published
January 2021
Pages
230
View Count
56
 |
 |
 |
 |
 |
 |
 |
 |
 |
Orthoclone OKT3® was the first monoclonal antibody-based drug (approved in 1986). As of today, more than 100 such products are available for therapeutic use across different geographies. Recently, Margenza™ (December 2020), Danyelza® (November 2020), Adakveo® (November 2019), Beovu® (October 2019), SKYRIZI™ (April 2019) and EVENITY™ (April 2019), were approved by the USFDA. Owing to their specificity for a target biomolecule (antigen) and favorable safety profile (compared to small molecule drugs), antibody-based interventions presently make up the largest class of biologic drugs. This trend is unlikely to change as multiple advanced variants of these drugs, such as bispecific antibodies and antibody fragments-based products, have been developed and several pharmacological leads based on these relatively novel constructs, are under evaluation. However, as is the case with all biologics, the production of antibodies is also a complex process. Specifically, antibody purification, which is one of the most crucial steps downstream of the manufacturing process, is a cost intensive operation. The investment of both effort and capital at this stage of production is justified because any impurity, or unwanted antibody molecule, poses a serious threat to not only therapeutic efficacy but also to the safety of patients. A variety of physiochemical approaches, including ammonium sulphate precipitation, hydrophobic interaction chromatography, ion-exchange chromatography and size exclusion chromatography techniques, are used to purify antibodies.
With the surge in demand for antibodies across research, diagnostic and therapeutic applications, there is now an urgent, parallel need to optimize production throughput. In this context, the purification aspect needs to be handled with extra caution, considering the dangers associated with contaminated medical products. Owing to prohibitive capital investments on purification infrastructure and the required expertise, not all therapy developers are able to establish in-house capabilities, especially at the larger (clinical and commercial) scales. Outsourcing is, therefore, a widely used operational model in this industry. The antibody purification services market today has evolved into a competitive domain, featuring the presence of start-ups, mid-sized companies and several established firms, some of which claim to offer end-to-end downstream processing solutions, as well. Moreover, such service-focused companies generally ensure that they have the latest upgrades in equipment and infrastructure, in order to differentiate themselves from the contemporary competition. Given the growing trend of outsourcing in the healthcare industry and the ongoing efforts of service providers to further improve / expand their respective portfolios, we believe the antibody purification services market is likely to evolve at a steady pace, till 2030.
The "Global Antibody Purification Services Market, 2020-2030" report features an extensive study on the current market landscape, offering an informed opinion on the future opportunities in this industry, over the next ten years. The study underlines an in-depth analysis of the purification services for antibodies offered by service providers, which are intended for use in various R&D and / or therapeutic purposes. In addition to other elements, it includes:
One of the key objectives of the report was to estimate the existing market size and the future opportunities within the antibody purification services market. Based on multiple parameters, such as projected growth of overall antibody-based products market, cost of goods sold and direct manufacturing costs, we have developed informed estimates on the financial evolution of the market over the period 2020-2030. The report also provides details on the likely distribution of the current and forecasted opportunity across [A] company size (small, mid-sized and large / very large), [B] type of antibody (monoclonal, polyclonal and others), [C] type of purification method (physio chemical, class specific and antigen affinity purification), [D] end user (pharmaceutical and biotechnology companies, and diagnostic laboratories) and [E] key geographies (North America, Europe, Asia Pacific, Middle East, North Africa (MENA), Latin America (LATAM).
To account for the uncertainties associated with this industry and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market's evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Chapter 2 is an executive summary of the insights captured in our research. The summary offers a high-level view on the likely evolution of the antibody purification services market in the mid to long term.
Chapter 3 In this chapter, we have briefly discussed the types of antibody purification methods. It highlights the need for outsourcing of antibody purification and the guidelines for selecting a service provider.
Chapter 4 provides an overview of the overall antibody purification services landscape, providing information on over 180 service providers that are currently active in this domain. It features an in-depth analysis of the market, based on year of establishment, company size, location of headquarters, sources of sources of antibodies and type of antibody (monoclonal, polyclonal and others), type of purification method (physio chemical, class specific and antigen affinity purification), application area (diagnostics, therapeutics and research) and end user (hospitals and clinics, industry and research institutes).
Chapter 5 provides an insightful competitiveness analysis of the antibody purification service providers that we came across during our research. The analysis compares the companies on the basis of supplier strength (experience of the service provider) and service portfolio strength (in terms of source of antibodies purified, type of antibody, type of purification method, application areas and end user).
Chapter 6 features detailed profiles of the key players active in the antibody purification services domain. Each company profile features a brief overview of the company, antibody purification service portfolio and an informed future outlook.
Chapter 7 chapter presents a detailed regional capability assessment framework which compares the capabilities of service providers (based on source of antibody, purification method and application area) across different regions.
Chapter 8 provides informed estimates of the annual commercial and clinical demand for antibodies, based on various relevant parameters, such as target patient population, dosing frequency and dose strength.
Chapter 9 presents a comprehensive market forecast analysis, highlighting the likely growth of antibody purification services market till the year 2030. The chapter provides likely distribution of the projected future opportunity based on company size (small, mid-sized and large / very large sized), type of antibody (monoclonal, polyclonal and others), type of purification method (physio chemical, class specific and antigen affinity purification), end user (hospitals and clinics, industry and research institutes) and key geographies (North America, Europe, Asia Pacific, MENA and LATAM).
Chapter 10 presents a detailed case study on market landscape of companies that offer contract services for manufacturing antibodies, including information on year of establishment, company size, scale of operation (preclinical, clinical and commercial), location of headquarters, number of manufacturing facilities and location of these facilities, type of antibody manufactured (monoclonal antibodies, bispecific antibodies and polyclonal antibodies), type of expression systems used (mammalian, microbial and others), fill / finish operations and affiliations to regulatory agencies.
Chapter 11 is a collection of interview transcripts of the discussions held with key stakeholders in the industry.
Chapter 12 summarizes the entire report. It presents a list of key takeaways and offers our independent opinion on the current market scenario.
Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures in the report.
Chapter 14 is an appendix, which provides the list of companies and organizations mentioned in the report.
1. PREFACE
1.1. Scope of the Report
1.2 Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2 Types of Antibody Purification Methods
3.3. Outsourcing Antibody Manufacturing and Purification Operations
3.3.1. Need for Outsourcing
3.3.2 Advantages of Outsourcing Purification Services
3.3.3 Guidelines for Selecting a Service Provider
3.3. Growth Drivers and Roadblocks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Antibody Purification Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Source of Antibody
4.2.5. Analysis by Type of Antibody
4.2.6. Analysis by Type of Purification Method
4.2.7. Analysis by Application Area
4.2.8. Analysis by End User
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Input Parameters
5.4. Company Competitiveness Analysis: Antibody Purification Service Providers in North America
5.5. Company Competitiveness Analysis: Antibody Purification Service Providers in Europe
5.6. Company Competitiveness Analysis: Antibody Purification Service Providers in Asia-Pacific and RoW
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Antibody Purification Service Providers: North America
6.2.1. Antibody Research
6.2.2.1 Company Overview
6.2.3.1 Antibody Purification Service Portfolio
6.2.2. Bio-synthesis
6.2.2.1. Company Overview
6.2.2.2 Antibody Purification Service Portfolio
6.2.3. SouthernBiotech
6.2.3.1 Company Overview
6.2.3.2 Antibody Purification Service Portfolio
6.2.3.3 Recent Developments and Future Outlook
6.2.4. Thermo Fisher Scientific
6.2.4.1 Company Overview
6.2.4.2 Antibody Purification Service Portfolio
6.2.4.3 Recent Developments and Future Outlook
6.2.5 Virusys
6.2.5.1 Company Overview
6.2.5.2 Antibody Purification Service Portfolio
6.3. Antibody Purification Service Providers: Europe
6.3.1 BBI Solutions
6.3.1.1 Company Overview
6.3.1.2 Antibody Purification Service Portfolio
6.3.2 RD Biotech
6.3.2.1 Company Overview
6.3.2.2 Antibody Purification Service Portfolio
6.4. Antibody Purification Service Providers: Asia Pacific
6.4.1. Allele life Sciences
6.4.1.1 Company Overview
6.4.1.2 Antibody Purification Service Portfolio
6.4.1.3 Recent Developments and Future Outlook
6.4.2 Detai Bio-Tech
6.2.2.1 Company Overview
6.2.3.2. Antibody Purification Services Portfolio
6.2.3.3. Recent Developments and Future Outlook
7. REGIONAL CAPABILITY ANALYSIS
7.1. Chapter Overview
7.2. Regional Capability Analysis: Antibody Purification Service Providers
7.2.1 Capabilities of Antibody Purification Service Providers based in North America
7.2.1.1 Capabilities of Antibody Purification Service Providers based in North America: Analysis by Company Size
7.2.1.2 Capabilities of Antibody Purification Service Providers based in North America: Analysis by Type of Antibody
7.2.1.3 Capabilities of Antibody Purification Service Providers based in North America: Analysis by Type of Purification Method
7.2.1.4 Capabilities of Antibody Purification Service Providers based in North America: Analysis by Application Area
7.2.2 Capabilities of Antibody Purification Service Providers based in Europe
7.2.2.1 Capabilities of Antibody Purification Service Providers based in Europe: Analysis by Company Size
7.2.2.2 Capabilities of Antibody Purification Service Providers based in Europe: Analysis by Type of Antibody
7.2.2.3 Capabilities of Antibody Purification Service Providers based in North America: Analysis by Type of Purification Method
7.2.2.4 Capabilities of Antibody Purification Service Providers based in North America: Analysis by Application Area
7.2.3 Capabilities of Antibody Purification Service Providers based in Asia Pacific and Rest of the World
7.2.3.1 Capabilities of Antibody Purification Service Providers based in Asia Pacific and Rest of the World: Analysis by Company Size
7.2.3.2 Capabilities of Antibody Purification Service Providers based in Asia Pacific and Rest of the World: Analysis by Type of Antibody
7.2.3.3 Capabilities of Antibody Purification Service Providers based in Asia Pacific and Rest of the World: Analysis by Type of Purification Method
7.2.3.4 Capabilities of Antibody Purification Service Providers based in Asia Pacific and Rest of the World: Analysis by Application Area
8. ANALYSIS OF DEMAND FOR PURIFICATION OF THERAPEUTIC ANTIBODIES
8.1. Chapter Overview
8.2. Assumptions and Methodology
8.3. Antibody Purification Market: Overall Annual Demand
8.3.1. Analysis by Scale of Operation
8.3.2. Analysis by Geography
9. MARKET FORECAST AND OPPORTUNITY ANALYSIS
9.1. Chapter Overview
9.2. Key Assumptions and Forecast Methodology
9.3. Global Antibody Purification Services Market, 2020-2030
9.3.1. Global Antibody Purification Services Market, 2020- 2030: Distribution by Company Size
9.3.2. Global Antibody Purification Services Market, 2020- 2030: Distribution by Type of Antibody
9.3.3. Global Antibody Purification Services Market, 2020-2030: Distribution by Type of Purification Method
9.3.4. Global Antibody Purification Services Market, 2020- 2030: Distribution by End User
9.3.5. Global Antibody Purification Services Market, 2020-2030: Geographical Distribution
9.4. Antibody Purification Services Market in North America, 2020-2030
9.4.1. Antibody Purification Services Market in North America, 2020-2030: Share of Small Companies
9.4.2. Antibody Purification Services Market in North America, 2020-2030: Share of Mid-sized Companies
9.4.3. Antibody Purification Services Market in North America, 2020-2030: Share of Large / Very Large Companies
9.4.4. Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Purification Method
9.4.5. Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Antibody
9.4.6. Antibody Purification Services Market in North America, 2020-2030: Distribution by End User
9.5. Antibody Purification Services Market in Europe, 2020-2030
9.5.1. Antibody Purification Services Market in Europe, 2020-2030: Share of Small Companies
9.5.2. Antibody Purification Services Market in Europe, 2020-2030: Share of Mid-Sized Companies
9.5.3. Antibody Purification Services Market in Europe, 2020-2030: Share of Large / Very Large Companies
9.5.4. Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Purification Method
9.5.5. Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Antibody
9.5.6. Antibody Purification Services Market in Europe, 2020-2030: Distribution by End User
9.6. Antibody Purification Services Market in Asia Pacific, 2020-2030
9.6.1. Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Small Companies
9.6.2. Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Mid-Sized Companies
9.6.3. Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Large / Very Large Companies
9.6.4. Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Purification Method
9.6.5. Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Antibody
9.6.6. Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by End User
9.7. Antibody Purification Services Market in Latin America, 2020-2030
9.7.1. Antibody Purification Services Market in Latin America, 2020-2030: Share of Small Companies
9.7.2. Antibody Purification Services Market in Latin America, 2020-2030: Share of Mid-Sized Companies
9.7.3. Antibody Purification Services Market in Latin America, 2020-2030: Share of Large / Very Large Companies
9.7.4. Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Purification Method
9.7.5. Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Antibody
9.7.6. Antibody Purification Services Market in Latin America, 2020-2030: Distribution by End User
9.8. Antibody Purification Services Market in Middle East and North Africa, 2020-2030
9.8.1. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Small Companies
9.8.2. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Mid-Sized Companies
9.8.3. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Large / Very Large Companies
9.8.4. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Purification Method
9.8.5. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Antibody
9.8.6. Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by End User
10. CASE STUDY: ANTIBODY CONTRACT MANUFACTURING MARKET LANDSCAPE
10.1. Chapter Overview
10.2. Antibody Contract Manufacturers: Overall Market Landscape
10.2.1. Analysis by Year of Establishment
10.2.2. Analysis by Company Size
10.2.3. Analysis by Scale of Operation
10.2.4. Analysis by Location of Headquarters
10.2.5. Analysis by Type of Antibody
10.2.6. Analysis by Expression System Used
10.2.7. Analysis by Regulatory Accreditations / Certifications
11. CONCLUDING REMARKS
12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. Abveris
12.2.1. Company Snapshot
12.2.2. Interview Transcript
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
List Of Figures
Figure 3.1 Methods Used for Physicochemical Fractionation
Figure 3.2 Steps Involved in Antigen-Specific Affinity Antibody Purification
Figure 3.3 Types of Third-Party Service Providers
Figure 3.4 Guidelines for Selecting an Antibody Purification Service Provider
Figure 3.5 Growth Drivers and Roadblocks for Antibody Manufacturing and Purification Operations
Figure 4.1 Antibody Purification Service Providers: Distribution by Year of Establishment
Figure 4.2 Antibody Purification Service Providers: Distribution by Company Size
Figure 4.3 Antibody Purification Service Providers: Distribution by Location of Headquarters
Figure 4.4 Antibody Purification Service Providers: Distribution by Source of Antibody
Figure 4.5 Antibody Purification Service Providers: Distribution by Type of Purification Method
Figure 4.6 Antibody Purification Service Providers: Distribution by Application Area
Figure 4.7 Antibody Purification Service Providers: Distribution by End User
Figure 5.1 Company Competitiveness: Antibody Purification Service Providers in North America
Figure 5.2 Company Competitiveness: Antibody Purification Service Providers in Europe
Figure 5.3 Company Competitiveness: Antibody Purification Service Providers in Asia-Pacific
Figure 5.4 Company Competitiveness: Antibody Purification Service Providers in Rest of the World
Figure 5.5 Company Competitiveness: Top Antibody Purification Service Providers
Figure 5.6 Spider Web Analysis: Benchmarking of Top Players
Figure 7.1 Capabilities of Antibody Purification Service Providers based in North America: Distribution by Type of Antibody
Figure 7.2 Capabilities of Antibody Purification Service Providers based in North America: Distribution by Type of Purification Method
Figure 7.3 Capabilities of Antibody Purification Service Providers based in North America: Distribution by Application Area
Figure 7.4 Capabilities of Antibody Purification Service Providers based in Europe: Distribution by Type of Antibody
Figure 7.5 Capabilities of Antibody Purification Service Providers based in Europe: Distribution by Type of Purification Method
Figure 7.6 Capabilities of Antibody Purification Service Providers based in Europe: Distribution by Application Area
Figure 7.7 Capabilities of Antibody Purification Service Providers based in Asia Pacific and RoW: Distribution by Type of Antibody
Figure 7.8 Capabilities of Antibody Purification Service Providers based in Asia Pacific and RoW: Distribution by Type of Purification Method
Figure 7.9 Capabilities of Antibody Purification Service Providers based in Asia Pacific and RoW: Distribution by Application Area
Figure 8.1 Demand Analysis: Annual Demand for Antibodies (in Kilograms)
Figure 8.2 Demand Analysis: Distribution by Scale of Operation (in Kilograms)
Figure 8.3 Demand Analysis: Distribution by Geographical Location
Figure 9.1 Global Antibody Purification Services Market, 2020-2030 (USD Billion)
Figure 9.2 Global Antibody Purification Services Market, 2020- 2030: Distribution by Company Size (USD Billion)
Figure 9.3 Global Antibody Purification Services Market, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.4 Global Antibody Purification Services Market, 2020- 2030: Distribution by Type of Antibody (USD Billion)
Figure 9.5 Global Antibody Purification Services Market, 2020- 2030: Distribution by End User (USD Billion)
Figure 9.6 Global Antibody Purification Services Market, 2020-2030: Distribution by Geography (USD Billion)
Figure 9.7 Antibody Purification Services Market in North America, 2020-2030 (USD Billion)
Figure 9.8 Antibody Purification Services Market in North America, 2020-2030: Share of Small Companies (USD Billion)
Figure 9.9 Antibody Purification Services Market in North America, 2020-2030: Share of Mid-sized Companies (USD Billion)
Figure 9.10 Antibody Purification Services Market in North America, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Figure 9.11 Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.12 Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Antibody (USD Billion)
Figure 9.13 Antibody Purification Services Market in North America, 2020-2030: Distribution by End User (USD Billion)
Figure 9.14 Antibody Purification Services Market in Europe, 2020-2030 (USD Billion)
Figure 9.15 Antibody Purification Services Market in Europe, 2020-2030: Share of Small Companies (USD Billion)
Figure 9.16 Antibody Purification Services Market in Europe, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Figure 9.17 Antibody Purification Services Market in Europe, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Figure 9.18 Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.19 Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Antibody (USD Billion)
Figure 9.20 Antibody Purification Services Market in Europe, 2020-2030: Distribution by End User (USD Billion)
Figure 9.21 Antibody Purification Services Market in Asia Pacific, 2020-2030 (USD Billion)
Figure 9.22 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Small Companies (USD Billion)
Figure 9.23 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Figure 9.24 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Figure 9.25 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.26 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Antibody (USD Billion)
Figure 9.27 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by End User (USD Billion)
Figure 9.28 Antibody Purification Services Market in Latin America, 2020-2030 (USD Billion)
Figure 9.29 Antibody Purification Services Market in Latin America, 2020-2030: Share of Small Companies (USD Billion)
Figure 9.30 Antibody Purification Services Market in Latin America, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Figure 9.31 Antibody Purification Services Market in Latin America, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Figure 9.32 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.33 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Antibody (USD Billion)
Figure 9.34 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by End User (USD Billion)
Figure 9.35 Antibody Purification Services Market in Middle East and North Africa, 2020-2030 (USD Billion)
Figure 9.36 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Small Companies (USD Billion)
Figure 9.37 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Figure 9.38 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Figure 9.39 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Figure 9.40 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Antibody (USD Billion)
Figure 9.41 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by End User (USD Billion)
Figure 10.1 Antibody Contract Manufacturers: Distribution by Year of Establishment
Figure 10.2 Antibody Contract Manufacturers: Distribution by Number of Employees
Figure 10.3 Antibody Contract Manufacturers: Distribution by Company Size
Figure 10.4 Antibody Contract Manufacturers: Distribution by Scale of Operation
Figure 10.5 Antibody Contract Manufacturers: Distribution by Location of Headquarters (Region-wise)
Figure 10.6 Antibody Contract Manufacturers: Distribution by Type of Antibody Manufactured
Figure 10.7 Antibody Contract Manufacturers: Distribution by Type of Antibody Manufactured and Geographical Location
Figure 10.8 Antibody Contract Manufacturers: Distribution by Type of Antibody and Company Size
Figure 10.9 Antibody Contract Manufacturers: Distribution by Type of Expression System Used
Figure 10.10 Antibody Contract Manufacturers: Distribution by Regulatory Accreditations / Certifications
Figure 11.1 Concluding Remarks: Market Landscape
Figure 11.2 Concluding Remarks: Partnerships and Collaborations
Figure 11.3 Concluding Remarks: Regional Capabilities
Figure 11.4 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 3.1 Ligands Used for Class-Specific Affinity Antibody Purification
Table 4.1 List of Antibody Purification Service Providers
Table 4.2 Antibody Purification Service Providers: Information on Source of Antibody
Table 4.3 Antibody Purification Service Providers: Information on Type of Antibody
Table 4.4 Antibody Purification Service Providers: Information on Purification Method
Table 4.5 Antibody Purification Service Providers: Information on Application Area
Table 4.6 Antibody Purification Service Providers: Information on End User
Table 6.1 Antibody Purification Services List of Profiled Companies
Table 6.2 2BScientifc: Company Snapshot
Table 6.3 2BScientifc: Service Portfolio
Table 6.4 2BScientifc: Recent Developments and Future Outlook
Table 6.5 AffinityImmuno: Company Snapshot
Table 6.6 AffinityImmuno: Service Portfolio
Table 6.7 AffinityImmuno: Recent Developments and Future Outlook
Table 6.8 Abcam: Company Snapshot
Table 6.9 Abcam: Service Portfolio
Table 6.10 Abcam: Recent Developments and Future Outlook
Table 6.11 BBI Solutions: Company Snapshot
Table 6.12 BBI Solutions: Service Portfolio
Table 6.13 BBI Solutions: Recent Developments and Future Outlook
Table 6.14 Creative Biolabs: Company Snapshot
Table 6.15 Creative Biolabs: Service Portfolio
Table 6.16 Creative Biolabs: Recent Developments and Future Outlook
Table 6.17 Detai Bio-Tech: Company Snapshot
Table 6.18 Detai Bio-Tech: Service Portfolio
Table 6.19 Detai Bio-Tech: Recent Developments and Future Outlook
Table 6.20 GE Healthcare: Company Snapshot
Table 6.21 GE Healthcare: Service Portfolio
Table 6.22 GE Healthcare: Recent Developments and Future Outlook
Table 6.23 GenScript: Company Snapshot
Table 6.24 GenScript: Service Portfolio
Table 6.25 GenScript: Recent Developments and Future Outlook
Table 6.26 Marine Biotechnology Services: Company Snapshot
Table 6.27 Marine Biotechnology Services: Service Portfolio
Table 6.28 Marine Biotechnology Services: Recent Developments and Future Outlook
Table 6.29 RayBiotech: Company Snapshot
Table 6.30 RayBiotech: Service Portfolio
Table 6.31 RayBiotech: Recent Developments and Future Outlook
Table 6.32 SouthernBiotech: Company Snapshot
Table 6.33 SouthernBiotech: Service Portfolio
Table 6.34 SouthernBiotech: Recent Developments and Future Outlook
Table 6.35 ThermoFisher Scientific: Company Snapshot
Table 6.36 ThermoFisher Scientific: Service Portfolio
Table 6.37 ThermoFisher Scientific Recent Developments and Future Outlook
Table 10.1 List of Antibody Contract Manufacturers
Table 10.2 Antibody Contract Manufacturers: Information on Scale of Operation
Table 10.3 Antibody Contract Manufacturers: Information on Type of Antibodies Manufactured
Table 10.4 Antibody Contract Manufacturers: Information on Expression Systems Used
Table 10.5 Antibody Contract Manufacturers: Information on Regulatory Accreditations / Certifications
Table 14.1 Antibody Purification Service Providers: Distribution by Year of Establishment
Table 14.2 Antibody Purification Service Providers: Distribution by Company Size
Table 14.3 Antibody Purification Service Providers: Distribution by Location of Headquarters
Table 14.4 Antibody Purification Service Providers: Distribution by Source of Antibody
Table 14.5 Antibody Purification Service Providers: Distribution by Type of Purification Method
Table 14.6 Antibody Purification Service Providers: Distribution by Application Area
Table 14.7 Antibody Purification Service Providers: Distribution by End User
Table 14.8 Company Competitiveness: Antibody Purification Service Providers in North America
Table 14.9 Company Competitiveness: Antibody Purification Service Providers in Europe
Table 14.10 Company Competitiveness: Antibody Purification Service Providers in Asia-Pacific
Table 14.11 Company Competitiveness: Top Antibody Purification Service Providers
Table 14.12 Spider Web Analysis: Benchmarking of Top Players
Table 14.13 Most Active Players: Analysis by Number and Type of Partnership
Table 14.14 Partnerships and Collaborations: Regional Analysis
Table 14.15 Capabilities of Antibody Purification Service Providers based in North America: Distribution by Type of Antibody
Table 14.16 Capabilities of Antibody Purification Service Providers based in North America: Distribution by Type of Purification Method
Table 14.17 Capabilities of Antibody Purification Service Providers based in North America: Distribution by End User
Table 14.18 Capabilities of Antibody Purification Service Providers based in Europe: Distribution by Type of Antibody
Table 14.19 Capabilities of Antibody Purification Service Providers based in Europe: Distribution by Type of Purification Method
Table 14.20 Capabilities of Antibody Purification Service Providers based in Europe: Distribution by End User
Table 14.21 Capabilities of Antibody Purification Service Providers based in Asia Pacific: Distribution by Type of Antibody
Table 14.22 Capabilities of Antibody Purification Service Providers based in Asia Pacific: Distribution by Type of Purification Method
Table 14.23 Capabilities of Antibody Purification Service Providers based in Asia Pacific: Distribution by End User
Table 14.24 Capabilities of Antibody Purification Service Providers based in Rest of the World: Distribution by Type of Antibody
Table 14.25 Capabilities of Antibody Purification Service Providers based in Rest of the World: Distribution by Type of Purification Method
Table 14.26 Capabilities of Antibody Purification Service Providers based in Rest of the World: Distribution by End User
Table 14.27 Demand Analysis: Annual Demand for Antibodies (in Kilograms)
Table 14.28 Demand Analysis: Distribution by Scale of Operation (in Kilograms)
Table 14.29 Demand Analysis: Distribution by Geographical Location
Table 14.30 Global Antibody Purification Services Market, 2020-2030 (USD Billion)
Table 14.31 Global Antibody Purification Services Market, 2020- 2030: Distribution by Company Size (USD Billion)
Table 14.32 Global Antibody Purification Services Market, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Table 14.33 Global Antibody Purification Services Market, 2020- 2030: Distribution by Type of Antibody (USD Billion)
Table 14.34 Global Antibody Purification Services Market, 2020- 2030: Distribution by End User (USD Billion)
Table 14.35 Global Antibody Purification Services Market, 2020-2030: Geographical Distribution (USD Billion)
Table 14.36 Antibody Purification Services Market in North America, 2020-2030 (USD Billion)
Table 14.37 Antibody Purification Services Market in North America, 2020-2030: Share of Small Companies (USD Billion)
Table 14.38 Antibody Purification Services Market in North America, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Table 14.39 Antibody Purification Services Market in North America, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Table 14.40 Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Table 14.41 Antibody Purification Services Market in North America, 2020-2030: Distribution by Type of Antibody (USD Billion)
Table 14.42 Antibody Purification Services Market in North America, 2020-2030: Distribution by End User (USD Billion)
Table 14.43 Antibody Purification Services Market in Europe, 2020-2030 (USD Billion)
Table 14.44 Antibody Purification Services Market in Europe, 2020-2030: Share of Small Companies (USD Billion)
Table 14.45 Antibody Purification Services Market in Europe, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Table 14.46 Antibody Purification Services Market in Europe, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Table 14.47 Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Table 14.48 Antibody Purification Services Market in Europe, 2020-2030: Distribution by Type of Antibody (USD Billion)
Table 14.49 Antibody Purification Services Market in Europe, 2020-2030: Distribution by End User (USD Billion)
Table 14.50 Antibody Purification Services Market in Asia Pacific, 2020-2030 (USD Billion)
Table 14.51 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Small Companies (USD Billion)
Table 14.52 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Table 14.53 Antibody Purification Services Market in Asia Pacific, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Table 14.54 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Table 14.55 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by Type of Antibody (USD Billion)
Table 14.56 Antibody Purification Services Market in Asia Pacific, 2020-2030: Distribution by End User (USD Billion)
Table 14.57 Antibody Purification Services Market in Latin America, 2020-2030 (USD Billion)
Table 14.58 Antibody Purification Services Market in Latin America, 2020-2030: Share of Small Companies (USD Billion)
Table 14.59 Antibody Purification Services Market in Latin America, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Table 14.60 Antibody Purification Services Market in Latin America, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Table 14.61 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Table 14.62 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by Type of Antibody (USD Billion)
Table 14.63 Antibody Purification Services Market in Latin America, 2020-2030: Distribution by End User (USD Billion)
Table 14.64 Antibody Purification Services Market in Middle East and North Africa, 2020-2030 (USD Billion)
Table 14.65 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Small Companies (USD Billion)
Table 14.66 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Mid-Sized Companies (USD Billion)
Table 14.67 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Share of Large / Very Large Companies (USD Billion)
Table 14.68 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Purification Method (USD Billion)
Table 14.69 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by Type of Antibody (USD Billion)
Table 14.70 Antibody Purification Services Market in Middle East and North Africa, 2020-2030: Distribution by End User (USD Billion)
Table 14.71 Antibody Contract Manufacturers: Distribution by Year of Establishment
Table 14.72 Antibody Contract Manufacturers: Distribution by Number of Employees
Table 14.73 Antibody Contract Manufacturers: Distribution by Company Size
Table 14.74 Antibody Contract Manufacturers: Distribution by Scale of Operation
Table 14.75 Antibody Contract Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 14.76 Antibody Contract Manufacturers: Distribution by Type of Antibodies Manufactured
Table 14.77 Antibody Contract Manufacturers: Distribution by Type of Antibodies Manufactured and Geography
Table 14.78 Antibody Contract Manufacturers: Distribution by Type of Antibodies and Company Size
Table 14.79 Antibody Contract Manufacturers: Distribution by Type of Expression System Used
Table 14.80 Antibody Contract Manufacturers: Distribution by Regulatory Accreditations / Certifications
Discounts available for multiple report purchases
sales@rootsanalysis.com